127 related articles for article (PubMed ID: 38281791)
41. Unusual Colonic Polyp in a Young Woman.
Bertolini R; Bode PK; Sawatzki M
Gastroenterology; 2021 Feb; 160(3):e12-e13. PubMed ID: 32598887
[No Abstract] [Full Text] [Related]
42. Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy.
Lin R; Mallick AB; Wang ZX; Brown SA; Lu B; Jiang W
Diagn Pathol; 2023 Oct; 18(1):116. PubMed ID: 37865792
[TBL] [Abstract][Full Text] [Related]
43. Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk.
Aepala MR; Peiris MN; Jiang Z; Yang W; Meyer AN; Donoghue DJ
Cytokine Growth Factor Rev; 2022 Dec; 68():93-106. PubMed ID: 36153202
[TBL] [Abstract][Full Text] [Related]
44. Identification of NTRK fusions in pediatric mesenchymal tumors.
Pavlick D; Schrock AB; Malicki D; Stephens PJ; Kuo DJ; Ahn H; Turpin B; Allen JM; Rosenzweig M; Badizadegan K; Ross JS; Miller VA; Wong V; Ali SM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097808
[TBL] [Abstract][Full Text] [Related]
45. Intraluminal EWSR1-CREB1 gene rearranged, low-grade myxoid sarcoma of the pulmonary artery resembling extraskeletal myxoid chondrosarcoma (EMC).
Opitz I; Lauk O; Schneiter D; Ulrich S; Maisano F; Weder W; Bode-Lesniewska B
Histopathology; 2019 Feb; 74(3):526-530. PubMed ID: 30326150
[No Abstract] [Full Text] [Related]
46. [CIC-rearranged sarcoma: a case report and literature review].
Sidorov IV; Fedorova AS; Konopleva EI; Makarova NP; Sharlai AS; Konovalov DM
Arkh Patol; 2023; 85(3):64-70. PubMed ID: 37272442
[No Abstract] [Full Text] [Related]
47. NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.
Wong DD; Vargas AC; Bonar F; Maclean F; Kattampallil J; Stewart C; Sulaiman B; Santos L; Gill AJ
Pathology; 2020 Jun; 52(4):401-409. PubMed ID: 32278476
[TBL] [Abstract][Full Text] [Related]
48.
Siozopoulou V; Marcq E; De Winne K; Norga K; Schmitz G; Duwel V; Delvenne P; Smits E; Pauwels P
Pathol Oncol Res; 2022; 28():1610423. PubMed ID: 35645621
[TBL] [Abstract][Full Text] [Related]
49. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas.
Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M
Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649
[No Abstract] [Full Text] [Related]
50. Cytomorphologic features of NTRK-rearranged thyroid carcinoma.
Viswanathan K; Chu YH; Faquin WC; Sadow PM
Cancer Cytopathol; 2020 Nov; 128(11):812-827. PubMed ID: 33074583
[TBL] [Abstract][Full Text] [Related]
51. Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
Simmons C; Deyell RJ; MacNeill AJ; Vera-Badillo FE; Smrke A; Abdul Razak AR; Banerji S; McLeod D; Noujaim J
Int J Cancer; 2021 Nov; 149(9):1691-1704. PubMed ID: 34213775
[TBL] [Abstract][Full Text] [Related]
52. Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Kummar S; Shen L; Hong DS; McDermott R; Keedy VL; Casanova M; Demetri GD; Dowlati A; Melcón SG; Lassen UN; Leyvraz S; Liu T; Moreno V; Patel J; Patil T; Mallick AB; Sousa N; Tahara M; Ziegler DS; Norenberg R; Arvis P; Brega N; Drilon A; Tan DSW
Cancer; 2023 Dec; 129(23):3772-3782. PubMed ID: 37769113
[TBL] [Abstract][Full Text] [Related]
53. [Clinicopathological features of gastric carcinomas with NTRK-rearrangement/amplification: report of four cases].
Xu AD; Fu Y; Pu XH; Wu HY; Sun Q; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):454-459. PubMed ID: 37106286
[No Abstract] [Full Text] [Related]
54. NTRK-rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class.
Tauziède-Espariat A; Duchesne M; Baud J; Le Quang M; Bochaton D; Azmani R; Croce S; Hostein I; Kesrouani C; Guillemot D; Pierron G; Bourdeaut F; Cardoen L; Hasty L; Lechapt E; Métais A; Chrétien F; Puget S; Varlet P; Le Loarer F
Histopathology; 2023 Mar; 82(4):596-607. PubMed ID: 36413100
[TBL] [Abstract][Full Text] [Related]
55. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
[TBL] [Abstract][Full Text] [Related]
56. A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma.
Bai C; Zhang L; Wang Y; You X; Ju Y; Sun T; Fan Z
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2933-2937. PubMed ID: 35933643
[TBL] [Abstract][Full Text] [Related]
57. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities.
Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G
Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613
[TBL] [Abstract][Full Text] [Related]
58. Infantile NTRK-associated Mesenchymal Tumors.
Davis JL; Lockwood CM; Albert CM; Tsuchiya K; Hawkins DS; Rudzinski ER
Pediatr Dev Pathol; 2018; 21(1):68-78. PubMed ID: 28683589
[TBL] [Abstract][Full Text] [Related]
59. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
Haberecker M; Töpfer A; Melega F; Moch H; Pauli C
Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438
[TBL] [Abstract][Full Text] [Related]
60. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
